| Bioactivity | Apafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors with a Ki of 9.9 nM[1]. | ||||||||||||
| Target | Ki: 9.9 nM (Platelet-activating factor) | ||||||||||||
| Name | Apafant | ||||||||||||
| CAS | 105219-56-5 | ||||||||||||
| Formula | C22H22ClN5O2S | ||||||||||||
| Molar Mass | 455.96 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Kato M, et al. Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs. J Pharmacol Sci. 2004 Aug;95(4):435-42. |
Apafant
CAS: 105219-56-5 F: C22H22ClN5O2S W: 455.96
Apafant (WEB 2086), a potent platelet-activating factor (PAF) antagonist, inhibits PAF binding to human PAF receptors wi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.